Rob Carlson, Managing Director of Bioeconomy Capital Dr. Rob Carlson is the Managing Director of Bioeconomy Capital. Rob is also a Principal at Biodesic, a strategy, engineering, and security consulting firm in Seattle that provides services to governments and corporations around the globe. At the broadest level, Dr. Carlson is interested in [...]
George Church, Professor at Harvard and MIT. George Church is Professor of Genetics at Harvard Medical School and Professor of Health Sciences and Technology at Harvard and the Massachusetts Institute of Technology (MIT). He is Director of the U.S. Department of Energy Center on Bioenergy at Harvard and MIT and Director of the [...]
Matt Angle, Founder and CEO, Paradromics Matt has a background in nanotechnology and neuroscience. As a graduate student at the Max Planck Institute for Medical Research and as a post-doctoral researcher at Stanford University, he was immersed in the development and the study of neural recording technologies. In the course of [...]
Toby Richardson, Co-founder, President and CEO of Denovium. Toby is the current Co-founder President and CEO of Denovium Inc, a newly formed company applying deep learning solutions to derive actionable knowledge from disparate biological data-sets. Previously he was VP of Informatics at Synthetic Genomics where he was responsible for the development [...]
Rachel Hovde, Head of Data Science at Chimera Bioengineering. Rachel discovered her interest in immunology while doing her graduate work in Statistics at Stanford, and looks for projects where she can create a mathematical picture of the immune system and combine it with the incredible lab research and medical work of [...]
Amanda Cashin, Co-Founder & VP, Illumina Accelerator Amanda Cashin, Ph.D. is Co-Founder and VP, Illumina Accelerator, a leading company creation engine and investment vehicle focused on building genomics-driven startups. Founded in Fall 2014 in San Francisco, Illumina Accelerator has invested in over 29 startups advancing breakthrough applications in genomics, including applications [...]
Will Canine, Co-Founder and CPO of Opentrons. Will comes from a background in community organizing and political campaign management, but decided to pursue technology as a more effective way to change the world. Obsessed with microbiology since an early age, Will became interested in open-source lab automation as a lever for [...]
Kunwoo Lee, Co-Founder and CEO of GenEdit Dr. Kunwoo Lee is the Co-Founder and CEO of GenEdit. He received a PhD from UC Berkeley in the Department of Bioengineering. He is the inventor of several delivery technologies for CRISPR/Cas9, which have shown great potential to revolutionize the treatment of genetic disorders. [...]
Tom Simmons, Founder and CEO of Stem. Tom Simmons is Founder and CEO of Stem, a food tech company based in Cambridge that is reimagining the role of sugar in our food. They make delicious and healthy food ingredients by purifying the natural, low calorie sugars found in plants. Tom is [...]
Lisa Nip, synthetic biologist at the MIT Media Lab. Lisa Nip is a synthetic biologist at the MIT Media Lab and has worked in various subfields of biology, including DNA lesions, DNA origami, and gene editing technologies. Her talk on how humans can leverage biotechnology to prepare themselves for long-term space [...]
